NeuroVasc Technologies Funding: $34M Raised, Series B (2020)
NeuroVasc Technologies is based in Greater Los Angeles Area. It has raised $34M in total funding. Latest round: Series B.
NeuroVasc Technologies funding overview
NeuroVasc Technologies is based in Greater Los Angeles Area. NeuroVasc Technologies has raised $34M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in February 2020. The round record for NeuroVasc Technologies runs through 2020; nothing later has been disclosed. Investors on record include ShangBay Capital, Shandong Weigao Group Medical Polymer Co., Limited. 2 distinct backers are named across the disclosed rounds.
NeuroVasc Technologies at a glance
Total raised
$34M
Latest round
Series B
Latest round date
February 2020
Headquarters
Greater Los Angeles Area
Notable investors
ShangBay Capital, Shandong Weigao Group Medical Polymer Co., Limited
Frequently asked about NeuroVasc Technologies funding
How much has NeuroVasc Technologies raised?
NeuroVasc Technologies has raised $34M in total disclosed funding across the rounds on record.
Who has invested in NeuroVasc Technologies?
ShangBay Capital, Shandong Weigao Group Medical Polymer Co., Limited are named among the investors backing NeuroVasc Technologies.
What was the latest NeuroVasc Technologies funding round?
The most recent disclosed round is a Series B, announced in February 2020.
Where is NeuroVasc Technologies based?
NeuroVasc Technologies is based in Greater Los Angeles Area.
When did NeuroVasc Technologies last raise?
The last disclosed NeuroVasc Technologies round closed in February 2020 at Series B.
Round data for NeuroVasc Technologies is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Greater Los Angeles Area and backer lists below.
